1. Home
  2. BLLN vs SYM Comparison

BLLN vs SYM Comparison

Compare BLLN & SYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

N/A

Current Price

$109.83

Market Cap

4.6B

Sector

Health Care

ML Signal

N/A

Logo Symbotic Inc.

SYM

Symbotic Inc.

N/A

Current Price

$37.13

Market Cap

5.3B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
BLLN
SYM
Founded
2016
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
5.3B
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
BLLN
SYM
Price
$109.83
$37.13
Analyst Decision
Buy
Buy
Analyst Count
8
18
Target Price
★ $129.00
$61.50
AVG Volume (30 Days)
456.0K
★ 1.6M
Earning Date
11-04-2026
11-23-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 103.40
N/A
EPS
★ 0.48
0.12
Revenue
$305,112,000.00
★ $2,246,922,000.00
Revenue This Year
$49.33
$24.53
Revenue Next Year
$26.38
$28.42
P/E Ratio
★ $237.01
$315.29
Revenue Growth
★ 99.97
25.65
52 Week Low
$61.96
$36.02
52 Week High
$150.44
$87.88

Technical Indicators

Market Signals
Indicator
BLLN
SYM
Relative Strength Index (RSI) 52.83 40.73
Support Level $89.26 N/A
Resistance Level $127.72 $44.26
Average True Range (ATR) 5.53 2.12
MACD 1.15 -0.20
Stochastic Oscillator 60.41 27.40

Price Performance

Historical Comparison
BLLN
SYM

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About SYM Symbotic Inc.

Symbotic Inc. is an automation technology company that develops solutions to improve operating efficiencies in modern warehouses. The group designs, commercializes, and deploys end-to-end technology systems that significantly enhance supply chain operations. The company automates the processing of pallets, cases, and individual items within warehouse environments. Its systems strengthen operations at the front end of the supply chain and provide benefits to all supply partners downstream. The company operates in two geographical regions: the United States and international markets, with the majority of its revenue generated in the United States.

Share on Social Networks: